Hemostasis Monitoring

For the past 40 years, ITC has been a world leader in the fields of hemostasis management and point-of-care testing.

Activated Clotting Time (ACT+ and ACT-LR), Activated Partial Thromboplastin Time (APTT and APTT Citrate), and Prothrombin Time (PT and PT Citrate) tests are general coagulation screening tests that are used to measure the functionality of the blood coagulation cascade. The ACT test is the method of choice for monitoring heparin therapy during cardiac surgery and PCI. Fresh whole blood is added to an activator (Celite®, silica, kaolin, or glass particles), and then timed for the formation of a clot. The type of activator used will affect the degree of prolongation of the ACT to a given heparin dose.

Hemochron® Fuldblodskoagulationssystemer

Hemochron ®Whole Blood Coagulation System
- Hemochron®Signature Elite
- Hemochron®  Signature Plus
Hemochron®  Tube technology
- Hemochron®  Response
- RxDx Dosing System